Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 73

Similar articles for PubMed (Select 23140350)

1.

PanelComposer: a web-based panel construction tool for multivariate analysis of disease biomarker candidates.

Jeong SK, Na K, Kim KY, Kim H, Paik YK.

J Proteome Res. 2012 Dec 7;11(12):6277-81. doi: 10.1021/pr3004387. Epub 2012 Nov 16.

PMID:
23140350
2.

Proteomic classification of pancreatic adenocarcinoma tissue using protein chip technology.

Scarlett CJ, Smith RC, Saxby A, Nielsen A, Samra JS, Wilson SR, Baxter RC.

Gastroenterology. 2006 May;130(6):1670-8. Epub 2006 Mar 6.

PMID:
16697731
3.

Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis.

Xue A, Scarlett CJ, Chung L, Butturini G, Scarpa A, Gandy R, Wilson SR, Baxter RC, Smith RC.

Br J Cancer. 2010 Jul 27;103(3):391-400. doi: 10.1038/sj.bjc.6605764. Epub 2010 Jun 29.

4.

Zinc α2-glycoprotein as a potential novel urine biomarker for the early diagnosis of prostate cancer.

Katafigiotis I, Tyritzis SI, Stravodimos KG, Alamanis C, Pavlakis K, Vlahou A, Makridakis M, Katafigioti A, Garbis SD, Constantinides CA.

BJU Int. 2012 Dec;110(11 Pt B):E688-93. doi: 10.1111/j.1464-410X.2012.11501.x. Epub 2012 Sep 28.

PMID:
23020913
5.

Translational biomarker discovery in clinical metabolomics: an introductory tutorial.

Xia J, Broadhurst DI, Wilson M, Wishart DS.

Metabolomics. 2013 Apr;9(2):280-299. Epub 2012 Dec 4.

6.

Application of HBx-induced anti-URGs as early warning biomarker of cirrhosis and HCC.

Wang W, Zhao LJ, Wang Y, Tao QY, Feitelson MA, Zhao P, Ren H, Qi ZT.

Cancer Biomark. 2011-2012;11(1):29-39. doi: 10.3233/CBM-2012-0261.

PMID:
22820138
7.

Exploring medical diagnostic performance using interactive, multi-parameter sourced receiver operating characteristic scatter plots.

Moore HE 4th, Andlauer O, Simon N, Mignot E.

Comput Biol Med. 2014 Apr;47:120-9. doi: 10.1016/j.compbiomed.2014.01.012. Epub 2014 Feb 3.

PMID:
24561350
8.

Comparison of proteomic biomarker panels in urine and serum for ovarian cancer diagnosis.

Petri AL, Simonsen AH, Høgdall E, Christensen IJ, Kjaer SK, Yip C, Risum S, Pedersen AT, Hartwell D, Fung ET, Høgdall C.

Proteomics Clin Appl. 2010 Mar;4(3):304-14. doi: 10.1002/prca.200900042. Epub 2010 Jan 4.

PMID:
21137051
9.

Identification of tear fluid biomarkers in dry eye syndrome using iTRAQ quantitative proteomics.

Zhou L, Beuerman RW, Chan CM, Zhao SZ, Li XR, Yang H, Tong L, Liu S, Stern ME, Tan D.

J Proteome Res. 2009 Nov;8(11):4889-905. doi: 10.1021/pr900686s.

PMID:
19705875
10.

Adjusting the generalized ROC curve for covariates.

Schisterman EF, Faraggi D, Reiser B.

Stat Med. 2004 Nov 15;23(21):3319-31.

PMID:
15490426
11.

pROC: an open-source package for R and S+ to analyze and compare ROC curves.

Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, Müller M.

BMC Bioinformatics. 2011 Mar 17;12:77. doi: 10.1186/1471-2105-12-77.

12.

Quantitation of plasma circulating DNA using quantitative PCR for the detection of hepatocellular carcinoma.

Huang Z, Hua D, Hu Y, Cheng Z, Zhou X, Xie Q, Wang Q, Wang F, Du X, Zeng Y.

Pathol Oncol Res. 2012 Apr;18(2):271-6. doi: 10.1007/s12253-011-9438-z. Epub 2011 Jul 21.

PMID:
21779787
13.

Serum ceruloplasmin as a diagnostic marker of cancer.

Senra Varela A, Lopez Saez JJ, Quintela Senra D.

Cancer Lett. 1997 Dec 23;121(2):139-45.

PMID:
9570351
14.

BiomarkerDigger: a versatile disease proteome database and analysis platform for the identification of plasma cancer biomarkers.

Jeong SK, Kwon MS, Lee EY, Lee HJ, Cho SY, Kim H, Yoo JS, Omenn GS, Aebersold R, Hanash S, Paik YK.

Proteomics. 2009 Jul;9(14):3729-40. doi: 10.1002/pmic.200800593.

PMID:
19639590
15.

A web-based tool for in silico biomarker discovery based on tissue-specific protein profiles in normal and cancer tissues.

Björling E, Lindskog C, Oksvold P, Linné J, Kampf C, Hober S, Uhlén M, Pontén F.

Mol Cell Proteomics. 2008 May;7(5):825-44. Epub 2007 Oct 3.

16.

Serum high mobility group box-1 is a powerful diagnostic and prognostic biomarker for pancreatic ductal adenocarcinoma.

Chung HW, Lim JB, Jang S, Lee KJ, Park KH, Song SY.

Cancer Sci. 2012 Sep;103(9):1714-21. doi: 10.1111/j.1349-7006.2012.02358.x. Epub 2012 Jul 30.

PMID:
22703527
17.

A CROC stronger than ROC: measuring, visualizing and optimizing early retrieval.

Swamidass SJ, Azencott CA, Daily K, Baldi P.

Bioinformatics. 2010 May 15;26(10):1348-56. doi: 10.1093/bioinformatics/btq140. Epub 2010 Apr 7.

18.

Fibro-α score as a simple and useful non-invasive test for predicting significant liver fibrosis in chronic hepatitis C patients.

Omran MM, Farid K, Emran TM, Attallah AA.

Arab J Gastroenterol. 2011 Jun;12(2):74-9. doi: 10.1016/j.ajg.2011.04.006. Epub 2011 May 17.

PMID:
21684477
19.

iTRAQ-2DLC-ESI-MS/MS based identification of a new set of immunohistochemical biomarkers for classification of dysplastic nodules and small hepatocellular carcinoma.

Jin GZ, Li Y, Cong WM, Yu H, Dong H, Shu H, Liu XH, Yan GQ, Zhang L, Zhang Y, Kang XN, Guo K, Wang ZD, Yang PY, Liu YK.

J Proteome Res. 2011 Aug 5;10(8):3418-28. doi: 10.1021/pr200482t. Epub 2011 Jun 21.

PMID:
21631109
20.

A prospective multicenter trial evaluating diagnostic validity of multivariate analysis and individual serum marker in differential diagnosis of pancreatic cancer from benign pancreatic diseases.

Hayakawa T, Naruse S, Kitagawa M, Ishiguro H, Kondo T, Kurimoto K, Fukushima M, Takayama T, Horiguchi Y, Kuno N, Noda A, Furukawa T.

Int J Pancreatol. 1999 Feb;25(1):23-9.

PMID:
10211418
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk